Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:01:37 EDT Sat 05 Jul 2025
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:CAPR
- CAPRICOR THERAPEUTICS INC -
https://www.capricor.com
13:01:37 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
CAPR
- Q
0.1
10.00
·
10.45
1.0
10.25
+0.23
2.3
758.4
10.14
10.56
10.1176
23.40 3.52
Jul 03
Jun 24
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - All 0 today
More trades...
Time ET
Ex
Price
Change
Volume
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2025-06-24 09:00
U:CAPR
News Release
200
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
2025-06-20 09:25
U:CAPR
News Release
200
Capricor Therapeutics Announces Positive 4-Year Data from HOPE-2 Open-Label Extension Study of Deramiocel in Duchenne Muscular Dystrophy
2025-06-17 09:00
U:CAPR
News Release
200
Capricor Therapeutics Announces Orphan Drug Designation for Becker Muscular Dystrophy and Regulatory Progress for Duchenne Muscular Dystrophy Program
2025-06-11 09:25
U:CAPR
News Release
200
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
2025-05-13 16:05
U:CAPR
News Release
200
Capricor Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
2025-05-13 09:00
U:CAPR
News Release
200
Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer
2025-05-06 09:15
U:CAPR
News Release
200
Capricor Therapeutics to Present First Quarter 2025 Financial Results and Recent Corporate Update on May 13
2025-05-05 08:00
U:CAPR
News Release
200
Capricor Therapeutics Announces Completion of Mid-Cycle Review Meeting with FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
2025-04-01 09:00
U:CAPR
News Release
200
Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day
2025-03-19 16:05
U:CAPR
News Release
200
Capricor Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
2025-03-17 09:25
U:CAPR
News Release
200
Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
2025-03-11 09:00
U:CAPR
News Release
200
Capricor Therapeutics to Present Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update on March 19
2025-03-10 09:13
U:CAPR
News Release
200
FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment
2025-03-07 09:25
U:CAPR
News Release
200
Capricor Therapeutics to Present at Leerink's Global Healthcare Conference 2025
2025-03-04 07:00
U:CAPR
News Release
200
Capricor Therapeutics Announces FDA Acceptance and Priority Review of its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy
2025-02-10 09:00
U:CAPR
News Release
200
Capricor Therapeutics to Participate in Upcoming Investor Conferences
2025-01-02 09:15
U:CAPR
News Release
200
Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
2024-12-02 16:15
U:CAPR
News Release
200
Capricor Therapeutics to Present at Upcoming Investor Conferences
2024-11-20 09:00
U:CAPR
News Release
200
Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency
2024-11-13 16:01
U:CAPR
News Release
200
Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update